Introducing our product range

cannaQIX® is the first and unique standardized nutraceutical containing hemp oil, vitamins and zinc aiming to reduce stress and to support psychological and nervous functions.

cannaQIX® 10

  • cannaQIX® is the first and unique standardized nutraceutical containing hemp oil, vitamins and zinc aiming to reduce stress and to support psychological and nervous functions1.
  • The effect is achieved due to its unique synergistic formula containing standardized hemp oil, vitamins, zinc and capsicum. 
  • The product is well tolerated, sugar free, non-euphoric and has no potential for addiction.
  • The standardized user friendly dose and formulation allows a precise control assuring a reliable and stable effect over several days.
  • The innovative buccal delivery system provides rapid absorption and high bioavailability.
  • The product is Swiss Made and produced in a GMP facility. The hemp is grown under GAP conditions. 


1EFSA claims: Niacin and the vitamins B6, B12 and C contribute to normal psychological function, to the reduction of tiredness and fatigue and to the normal function of the nervous system.

New study shows: cannaQIX® reduces stress

Creso Pharma shows significant reduction of stress with cannaQIX® in a recently completed open label observational prospective study

  • Successful completion of an open label prospective observational study with 25 subjects, in which stress reduction and other potential benefits were tested with cannaQIX® in the PARAMED clinic in Switzerland
  • The 12-month study program started in January 2019 - cannaQIX® usage was measured over two and four weeks
  • The study shows a statistically significant reduction in stress levels using the validated PSS instrument (Perceived Stress Scale)

Creso Pharma Limited (ASX: CPH) is pleased to announce that a prospective observational study has been successfully completed between January and December 2019. This study investigated the effect of cannaQIX® on stress and pain using two validated instruments in 25 subjects over 2 and 4 weeks. A statistically significant reduction in the stress level using PSS (Perceived Stress Scale) was demonstrated. The study also shows a statistically significant reduction in the use of stress medication. There was also a trend in the reduction of pain via P-FIBS (Pain, Frequency Intensity Burden Scale) but it did not reach statistical significance. 

Stress reduction strengthens the immune system

The unique formulation of cannaQIX® is based on hemp oil and supporting vitamins such as vitamins C, B3, B6, B12 and zinc. Providing effective support to reduce stress levels, especially in times of crisis, shows the most important advantages cannaQIX® can offer people in stressful situations. It is also known and clinically proven that stress reduction supports the immune system.

As mentioned in the publication by Dhabar et al., Neuroimmodulation, June 2009: “Stress is known to suppress immune function and increase susceptibility to infections and cancer. Chronic or long-term stress can suppress immunity by reducing the number and function of the immune cells and / or increasing the active immunosuppressive mechanisms (e.g. regulatory T cells). "

  Neuroimmune modulation. 2009; 16 (5): 300-17. doi: 10.1159 / 000216188. Epub 2009 Jun 29

cannaQIX® is sold in pharmacies and drugstores in Switzerland promoted by Doetsch Grether and in UK with Pharmacare, Boots, Holland & Barrett as well as online, and in Australia and New Zealand on prescription.

Dr. Simon Feldhaus added: “This first study with cannaQIX®, a natural hemp-based dietary supplement, has shown that it can offer significant benefits to users suffering from stress. We consider this study an interesting milestone for the successful use of hemp oil products to reduce stress.“ 

The study will be published and made available to medical professionals


CRESO Pharma Switzerland uses cookies to optimise and improve the website, as well as enable the availability of certain functions. By continuing to use this website, you agree to our use of cookies. For further information on how we use cookies, please click here.